Table 1.
Age-standardized rates (per 100,000) and male/female ratios of urologic cancer by sex in Korea, 1999-2012
| Site (ICD-10) | Overall |
Male |
Female |
Male/female ratio | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No. of cases (%) | ASR | APC | No. of cases (%) | ASR | APC | No. of cases (%) | ASR | APC | ||
| Kidney (C64) | 36,836 (23.61) | 4.40 | 5.80* | 25,252 (18.90) | 6.53 | 5.52* | 11,584 (51.71) | 2.61 | 5.68* | 2.50 |
| Bladder (C67) | 41,549 (26.64) | 4.79 | –0.40 | 33,180 (24.84) | 9.15 | –0.59 | 8,369 (37.36) | 1.62 | –0.99* | 5.65 |
| Prostate (C61) | 66,812 (42.83) | 7.75 | 12.96* | 66,812 (50.01) | 19.03 | 11.57* | - | - | - | - |
| Renal pelvis, ureter (C65, C66) | 7,537 (4.83) | 0.88 | 3.76* | 5,088 (3.81) | 1.39 | 2.86* | 2,449 (10.93) | 0.49 | 5.19* | 2.86 |
| Testis (C62) | 2,439 (1.56) | 0.35 | 4.49* | 2,439 (1.83) | 0.68 | 4.38* | - | - | - | - |
| Penis (C60) | 818 (0.52) | 0.09 | –2.01 | 818 (0.61) | 0.22 | –2.65* | - | - | - | - |
| Total | 155,991 (100) | 18.26 | 6.39* | 133,589 (100) | 37.00 | 6.34* | 22,402 (100) | 4.72 | 3.23* | 7.84 |
ICD-10, International Classification of Diseases, 10th edition; ASR, age-standardized rate (world standard population); APC, annual percentage change.
*
is significant at 0.05 significance level.